Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries-Reference-Cited by-同舟云学术

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Published:2020-01 Issue:1 Volume:19 Page:68-79
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Volkova Nataliya,Moy Kristin,Evans Jennifer,Campbell Daniel,Tian Simon,Simard Christopher,Higgins Mark,Konstan Michael W.,Sawicki Gregory S.,Elbert Alexander,Charman Susan C.,Marshall Bruce C.,Bilton Diana

Funder

Vertex Pharmaceuticals Incorporated

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference34 articles.

1. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis;Goss;Thorax,2007

2. Predictive 5-year survivorship model of cystic fibrosis;Liou;Am J Epidemiol,2001

3. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis;Britto;Chest,2002

4. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis;Konstan;J Pediatr,2007

5. Cystic fibrosis;O'Sullivan;Lancet,2009

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Care and Outcomes for Children with Cystic Fibrosis;Clinics in Chest Medicine;2024-09

2. Cystic fibrosis cell models for high-throughput analysis and drug screening;Journal of Cystic Fibrosis;2024-07

3. Real-world impact of ivacaftor in people with cystic fibrosis and select ivacaftor-responsive mutations;BMJ Open Respiratory Research;2024-07

4. Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis;Thorax;2024-06-27

5. Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by antiinflammatory drugs;JCI Insight;2024-06-18